The EarlyTox™ Cardiotoxicity Kit provides a fast, simple and reliable fluorescence based method for identifying cardiotoxic compounds in a biorelevant assay using stem-cell derived cardiomyocytes.

• Eliminate cardiotoxic compounds and identify potential drug candidates
• Measure 384 samples in minutes rather than hours
• Minimise non specific effect of dye on beat characteristics
• Reduce well-to-well variation and improve data quality
• Largest signal dynamic range available
• Benchmark against three reference compounds

For researchers looking to identify cardiotoxic compounds, the EarlyTox™ Cardiotoxicity Kit allows screening of more compounds earlier in drug discovery. This makes it possible to prioritise leads and direct medicinal chemistry efforts sooner, improving productivity and reducing costs associated with extensive safety testing downstream.